CIK: 0001687078 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $581,678 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 7,648,268 | $57,897 | 10.0% | $40.60 | -76.4% | Common | 230031106 |
| MDGL | Madrigal Pharmaceuticals Inc | 100,415 | $33,260 | 5.7% | $328.59 | 0.0% | Common | 558868105 |
| ZLAB | Zai Lab Ltd | 833,659 | $30,128 | 5.2% | $26.59 | — | ADR | 98887Q104 |
| EWTX | Edgewise Therapeutics Inc | 1,105,444 | $24,320 | 4.2% | $19.54 | +34.3% | Common | 28036F105 |
| LNTH | Lantheus Holdings Inc | 232,387 | $22,681 | 3.9% | $82.12 | +13.9% | Common | 516544103 |
| PTCT | PTC Therapeutics Inc | 439,977 | $22,421 | 3.9% | $40.98 | +21.8% | Common | 69366J200 |
| NTRA | Natera Inc | 157,047 | $22,208 | 3.8% | $76.08 | +111.3% | Common | 632307104 |
| TRVI | Trevi Therapeutics Inc | 3,428,366 | $21,564 | 3.7% | $2.95 | +61.6% | Common | 89532M101 |
| CRNX | Crinetics Pharmaceuticals Inc. | 631,964 | $21,196 | 3.6% | $29.47 | +26.7% | Common | 22663K107 |
| RNAM | Avidity Biosciences Inc | 714,224 | $21,084 | 3.6% | $40.60 | -23.3% | Common | 05370A108 |
| GH | Guardant Health Inc | 442,656 | $18,857 | 3.2% | $23.27 | +85.4% | Common | 40131M109 |
| UTHR | United Therapeutics Corp. | 58,907 | $18,159 | 3.1% | $352.41 | -2.8% | Common | 91307C102 |
| SPRY | ARS Pharmaceuticals Inc | 1,313,104 | $16,519 | 2.8% | $12.03 | 0.0% | Common | 82835W108 |
| CMPX | Compass Therapeutics, Inc. | 8,442,783 | $16,041 | 2.8% | $1.57 | +68.9% | Common | 20454B104 |
| JANX | Janux Therapeutics Inc | 567,193 | $15,314 | 2.6% | $41.03 | -8.1% | Common | 47103J105 |
| RARE | Ultragenyx Pharmaceutical Inc | 398,445 | $14,428 | 2.5% | $46.13 | -9.8% | Common | 90400D108 |
| MLTX | Moonlake Immunotherapeutics | 316,049 | $12,348 | 2.1% | $29.33 | +46.9% | Class A Ord | 61559X104 |
| WVE | Wave Life Sciences PTE LTD | 1,509,580 | $12,197 | 2.1% | $10.27 | +6.5% | Common | Y95308105 |
| RVMD | Revolution Medicines, Inc. | 317,083 | $11,212 | 1.9% | $29.31 | +38.5% | Common | 76155X100 |
| ALKS | Alkermes Plc | 337,603 | $11,148 | 1.9% | $32.61 | 0.0% | Common | G01767105 |
| OLMA | Olema Pharmaceuticals, Inc. | 2,930,446 | $11,018 | 1.9% | $9.76 | -48.5% | Common | 68062P106 |
| RCKT | Rocket Pharmaceuticals, Inc. | 1,618,265 | $10,794 | 1.9% | $16.57 | -40.4% | Common | 77313F106 |
| — | iTeos Therapeutics, Inc. | 1,745,943 | $10,423 | 1.8% | $24.67 | — | Common | 46565G104 |
| RNAC | Cartesian Therapeutics Inc | 790,779 | $10,422 | 1.8% | $19.06 | -6.3% | Common | 816212302 |
| TWST | Twist Bioscience Corp | 261,215 | $10,255 | 1.8% | $47.58 | -5.3% | Common | 90184D100 |
| XENE | Xenon Pharmaceuticals Inc | 303,398 | $10,179 | 1.7% | $39.60 | -4.1% | Common | 98420N105 |
| VERA | Vera Therapeutics Inc. | 415,719 | $9,986 | 1.7% | $39.66 | -19.0% | Class A Ord | 92337R101 |
| REPL | Replimune Group Inc | 987,036 | $9,624 | 1.7% | $12.16 | +1.8% | Common | 76029N106 |
| IOVA | Iovance Biotherapeutics Inc | 2,708,582 | $9,020 | 1.6% | $9.89 | -47.8% | Common | 462260100 |
| CNTX | Context Therapeutics Inc | 14,705,882 | $9,000 | 1.5% | $1.73 | -49.7% | Common | 21077P108 |
| MBX | MBX Biosciences Inc | 1,132,950 | $8,361 | 1.4% | $10.57 | 0.0% | Common | 55287L101 |
| NUVB | Nuvation Bio Inc | 4,652,243 | $8,188 | 1.4% | $2.54 | -10.5% | Common | 67080N101 |
| ORIC | Oric Pharmaceuticals Inc | 1,399,514 | $7,809 | 1.3% | $8.74 | 0.0% | Common | 68622P109 |
| IDYA | Ideaya Biosciences, Inc. | 430,161 | $7,046 | 1.2% | $28.05 | -24.0% | Common | 45166A102 |
| SLDB | Solid Biosciences Inc | 1,642,356 | $6,077 | 1.0% | $4.28 | 0.0% | Common | 83422E204 |
| RLAY | Relay Therapeutics Inc. | 2,295,924 | $6,015 | 1.0% | $10.70 | -63.4% | Common | 75943R102 |
| STOK | Stoke Therapeutics Inc | 693,988 | $4,615 | 0.8% | $13.55 | -31.2% | Common | 86150R107 |
| — | Veru Inc. | 6,592,727 | $3,231 | 0.6% | $0.59 | — | Common | 92536C103 |
| HOWL | Werewolf Therapeutics, Inc. | 2,408,810 | $2,341 | 0.4% | $13.70 | -90.4% | Common | 95075A107 |
| DSGN | Design Therapeutics Inc | 562,943 | $2,173 | 0.4% | $5.79 | -17.6% | Common | 25056L103 |
| ADAPY | Adaptimmune Therapeutics plc | 4,894,344 | $964 | 0.2% | $0.93 | — | Sponsored ADR | 00653A107 |
| — | Repare Therapeutics, Inc. | 819,924 | $808 | 0.1% | $31.02 | — | Common | 760273102 |
| ALXO | ALX Oncology Holdings Inc. | 550,000 | $343 | 0.1% | $10.00 | -88.0% | Common | 00166B105 |